4 Sept 2026Open access
Nanopore sequencing panel for saliva-based host pharmacogenomic screening in anti-tubercular therapyPublisher sitemedRxiv, Tuberculosis Research and Epidemiology
UniversitiesPaolo Denti
Active, last published 2026
In hiv/aids drug development and treatment
Paolo
Denti
Scholar“Research focused on HIV/AIDS drug development and treatment and adjacent fields.”
University of Cape Town
Claim Your Profile37
H-index
4.6k
Citations
Paolo has not officially claimed their profile. If you are Paolo, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
aolo Denti is a researcher working on HIV/AIDS drug development and treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Paolo's work has been cited 4,588 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
HIV/AIDS drug development and treatment×89Tuberculosis Research and Epidemiology×78Antibiotics Pharmacokinetics and Efficacy×41Pneumocystis jirovecii pneumonia detection and treatment×39Pharmacological Effects and Toxicity Studies×30
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Cape TownDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
11 works18 Dec 20252cites
Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysisPublisher siteEuropean Respiratory Journal, Tuberculosis Research and Epidemiology
26 Sept 2025Open access1cites
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIVPublisher siteAntimicrobial Agents and Chemotherapy, HIV/AIDS drug development and treatment
9 Dec 2024Open access4cites
Advancing pharmacometrics in Africa—Transition from capacity development toward job creationPublisher siteCPT Pharmacometrics & Systems Pharmacology, Biosimilars and Bioanalytical Methods
20 Sept 2024Open access4cites
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIVPublisher siteJournal of Antimicrobial Chemotherapy, HIV/AIDS drug development and treatment
22 Jul 2024Open access2cites
Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapyPublisher siteAntimicrobial Agents and Chemotherapy, HIV/AIDS drug development and treatment
10 Jul 2024Open access5cites
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugsPublisher siteJournal of Antimicrobial Chemotherapy, Tuberculosis Research and Epidemiology
8 May 2024Open access5cites
Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trialPublisher siteTrials, Pneumocystis jirovecii pneumonia detection and treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Paolo?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you